AEYRIE REIFF: Open Payments
NPI 1730646480 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 15 payments from 11 companies in 2025. Trend: 2023 $337 · 2024 $366 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| ABBVIE INC. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| PFIZER INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Optinose US, Inc. | 1 | $17 |
Products named: MOUNJARO, AIRSUPRA, UBRELVY, Veozah, ZEPBOUND, NURTEC ODT, JARDIANCE, Ozempic.
Industry payments across AZ — which companies pay providers there.
